The story of HIV is one of some of the greatest breakthroughs in modern medicine. What once was a near-certain death sentence has been transformed by Antiretroviral Therapy (ART) into a manageable chronic disease. Today, millions of people living with HIV — when treated properly and consistently — can lead long, healthy lives and, crucially, have virtually no risk of transmitting the virus sexually.
Here’s why that matters — and what it could mean for another great challenge in medicine: Cancer.
—
A Therapeutic Triumph in HIV
ART works by stopping HIV from making copies of itself. When someone takes their medication exactly as prescribed, most are able to reach what is called an “undetectable viral load” within about six months.
What does “undetectable” mean? It means the amount of HIV in the blood is so low that standard lab tests cannot detect it. Importantly: people living with HIV who maintain that undetectable level can’t pass the virus to sexual partners (this message is widely known as “U = U” or Undetectable = Untransmittable).
This is a turning point: not just treating the infection in the person, but also stopping the chain of transmission. It’s a dual benefit — for individual health and public health.
—
The Parallel: Cancer as the Next Frontier
Cancer is different from HIV in many ways — but there is hope in how we view it. Historically, many cancers were treated with the idea of “go big and cure if you can”. Today, even when curing isn’t possible, the goal is evolving: think of “control” rather than elimination. For some patients, cancer is starting to behave like a chronic disease — something that can be managed, monitored and lived with.
In fact, advances in treatment modalities — like targeted therapies, immunotherapy, gene therapy and personalized medicine — are helping to shift this paradigm. Researchers say: we’re increasingly able to keep cancer in check, suppress progression, and maintain quality of life.
—
What We Can Learn From HIV
1. Early treatment matters. In HIV care, starting ART early helps preserve the immune system and achieve suppression faster.
Similarly, in cancer the earlier we detect and treat, the better the outcomes tend to be.
2. Adherence + monitoring = success. For HIV, staying on ART and monitoring viral load is critical to remaining undetectable. Missing doses means viral load can rebound and transmission becomes possible again.
In cancer care, staying consistent with treatment, monitoring biomarkers and imaging, and adapting treatment when needed are key to transforming cancer into a manageable state.
3. Public health benefit of individual control. With HIV, when one person achieves suppression, they reduce their own risk and also the risk of transmitting the virus to others. That collective benefit is powerful.
In cancer, while the transmission component isn’t relevant, the lessons about sustained control, quality of life and long-term management shape how we might treat cancer long term.
4. From “fatal” to “manageable”. HIV used to mean likely death; now for many it means a chronic condition like diabetes or heart disease. We can imagine a future where some cancers follow a similar pathway — not necessarily cured completely, but held in check, with scheduled monitoring, therapies and life moving on.
—
Why It’s Still A Big Challenge
Of course, cancer presents complexities far beyond those faced in HIV. Tumours are extremely diverse, change over time, become resistant, and vary from person to person.
Moreover, the “cure” concept in HIV is still elusive (there is HIV in reservoirs even when viral load is undetectable).
And in cancer, dealing with metastases, drug resistance, late-stage disease means that for many, the ideal of “manageable chronic condition” is still aspirational.
—
The Vision Ahead
But the vision is inspiring. Imagine a cancer patient diagnosed with a tumour that cannot be completely removed, but through targeted therapy and regular monitoring, the tumour remains stable, side-effects are minimised, quality of life preserved. Think of the patient visiting their oncologist regularly, managing medication, checking biomarkers – living with the disease, not being consumed by it.
That’s the spirit of the HIV story that we hope to repeat in oncology. ART teaches us that when treatment is accessible, effective and adhered to, the landscape of a disease can change dramatically. It gives hope that cancers, once uniformly fatal, may join the ranks of treatable chronic conditions.
—
Take-away Message
We have come a long way with HIV because of ART, strong monitoring, public health investment, and patient empowerment. Now, as we apply similar dedication in cancer care — with newer therapies, precision medicine and patient-centred models — there is hope. Hope that more cancers can be controlled long term, hope that living with cancer can again mean living.
Let us keep pushing toward that goal. Because if ART taught us anything, it’s this: with science + persistence + care, transformation happens. For HIV it already did. For cancer, we are moving in the right direction.
—
Sources:
National Institute of Allergy and Infectious Diseases. “10 Things to Know About HIV Suppression.”
HIV.gov. “Viral Suppression and an Undetectable Viral Load.”
Centres for Disease Control and Prevention (CDC). “Undetectable = Untransmittable (U=U).”
World Health Organization. “New WHO guidance on HIV viral suppression and scientific updates.”
Nature Reviews / Sciences. “Exploring treatment options in cancer: tumor… ”
Cancer.org. “Managing Cancer as a Chronic Illness.”